doxorubicin prodrug (Dendreon)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedoxorubicin prodrug (Dendreon)
Drug Alias Namedoxorubicin prodrug (Dendreon)doxorubicin prodrug (Corvas)CVS-10290
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUrokinase plasminogen activator modulatorsTopoisomerase II inhibitorsVirus DNA polymerase inhibitors
TargetsVirus DNA polymeraseTopoisomerase IIUrokinase plasminogen activator
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDendreon San Diego Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDendreon San Diego Llc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A